The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development
Manica Balasegaram, Laura J. V. Piddock
Abstract
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
Topics & Concepts
General partnershipAntibioticsDrug developmentIntensive care medicineMedicineSepsisBusinessImmunologyDrugMicrobiologyBiologyFinancePsychiatryAntibiotic Use and ResistanceAntibiotic Resistance in BacteriaNeonatal and Maternal Infections